Bio Decontamination Market Size & Share Analysis - Growth Trends & Forecasts (2023 - 2028)

Bio Decontamination Market Analysis

The bio-decontamination market is projected to register a CAGR of 6.2% during the forecast period (2022 - 2027).

As the impact of the COVID-19 outbreak widens and the number of patients being admitted to hospitals grows, medical professionals and hospital administrators were looking for emergency alternatives that provide more beds for patients during the crisis by leveraging empty facilities, re-purposing space within an existing hospital, or building temporary structures to serve as hospitals, many options are being implemented to best serve the public as the Coronavirus spreads.​ Hospital-acquired COVID-19 represents a serious public health issue, which is a problem that creates reluctance of patients to seek hospital treatment for fear of becoming infected. As per the article titled “Hospital-Acquired SARS-Cov-2 Infections in Patients: Inevitable Conditions or Medical Malpractice?” published in January 2021, the SARS-CoV-2 hospital-acquired infection rate is 12–15% globally.​ According to the study “Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus–Infected Pneumonia in Wuhan, China” published in February 2020, Hospital-associated transmission was suspected in 12.3% of hospitalized patients initially admitted for other health issues. Thus, with the high incidence of hospital-acquired infections during the Coronavirus times, healthcare facilities are taking more care of hygiene in the healthcare facilities, thus driving the growth of the market.​ Hence, due to the pandemic, the necessity to use sterilization has increased, and the market is expected to grow duringh the forecast period. 

Prevention of hospital-acquired infections is a critical aspect of clinical management of COVID-19, as hospital-acquired infections have been a common feature of novel coronavirus outbreaks. As per the article titled “Hospital-Acquired SARS-CoV-2 Infection in the United Kingdom's first COVID-19 pandemic wave” published in August 2021, 11.3% of patients with COVID-19 in 314 United kingdom hospitals became infected after hospital admission. This rate increased to 15.8% in May 2020. Thus, the outbreak has impacted the healthcare facilities in managing hospital-acquired infections.​ Hospital-acquired infections (HAI) are nosocomially acquired infections that are not present or incubating at the time of admission to a hospital. These infections are contracted because of an infection or toxin in hospitals.​ These infections include catheter-associated urinary tract infections, central line-associated bloodstream infections, surgical site infections, ventilator-associated pneumonia, hospital-acquired pneumonia, and Clostridium difficile infections.​ 

The risk factors for HAI include immunosuppression, older age, length of stay in the hospital, multiple underlying comorbidities, frequent visits to healthcare facilities, mechanical ventilatory support, recent invasive procedures, indwelling devices, and stay in an intensive care unit (ICU).​ According to World Health Organization(WHO) report in October 2021, the elderly population is at high risk of contracting infectious diseases as they frequently visit hospitals and have poor immune systems. Thus, the growing geriatric population is expected to boost the incidence of HAI as the aging population would have a weak immune system, increasing their chances of getting infected, thus driving the market.​ Persons with multiple underlying comorbidities such as cardiovascular diseases, blood diseases, diabetes, cancer, etc., are more prone to HAIs. According to the article titled 'Anemia among Women of Reproductive Age: An Overview of Global Burden, Trends, Determinanrs and Drivers of Progress in Low- Middle-Income Countries'published in August 2021 in non-pregnant women of reproductive age was 29%, in pregnant women was 38%. These people report frequent hospital visits and are at higher risk of infections, thus driving the market. Thus, owing to the abovementioned factors, the studied market is expected to grow significantly over the forecast period.​

However, limitations in reallocating resources and adjusting budgets in health care may hamper the usefulness of economic evaluation for decision-making as limited resources would hinder the adoption rate of bio-decontamination devices and services. Thus, budgetary constraints in healthcare facilities are expected to hinder the market growth.

Bio Decontamination Market Trends

This section covers the major market trends shaping the Bio Decontamination Market according to our research experts:

Hospitals & Healthcare Facilities are Expected to Hold a Significant Market Share Over the Forecast Period

Bio Decontamination Industry Segmentation

As per the scope, bio-decontamination involves using biological decontamination agents to clean the surroundings. The main motive of bio-decontamination is to check the spread of microorganisms and other hazardous contaminants that may risk the health of humans and animals. The Bio Decontamination Market is Segmented by Product & Service (Equipment, Services, and Consumables), Agent Type (Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, and Nitrogen Dioxide), End User (Pharmaceutical & Medical Device Manufacturing Companies, Life Sciences & Biotechnology Research Organizations, and Hospitals & Healthcare Facilities), and Geography (North America, Europe, Asia-Pacific, and Rest of the World). The market report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.